Expert Review of Anticancer Therapy

Title Publication Date Language Citations
Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer2006/04/01English45
Diagnosis and treatment of carcinoid tumors2003/12/01English45
Rituximab (Rituxan®/MabThera®): the first decade (1993–2003)2003/12/01English44
Gemcitabine (Gemzar®) in non-small cell lung cancer2004/06/01English44
Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat2006/12/01English44
Adjuvant therapy in colon cancer2012/01/01English44
Seizures in low- and high-grade gliomas: current management and future outlook2010/05/01English44
Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends2010/04/01English44
Sorafenib: delivering a targeted drug to the right targets2007/05/01English44
Predictive and prognostic factors for gliomas2011/05/01English44
Perineural invasion and spread in head and neck cancer2012/03/01English44
Cancer and the microbiome: potential applications as new tumor biomarker2014/12/15English44
Targeting events in melanoma carcinogenesis for the prevention of melanoma2006/11/01English43
Anticancer treatments and female fertility: clinical concerns and role of oncologists in oncofertility practice2017/06/05English43
Surgical options and outcomes in bone sarcoma2006/02/01English43
Emerging therapies for adult soft tissue sarcoma2014/02/20English43
Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies2019/11/27English42
Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes2016/02/26English42
Autocrine motility factor receptor: a clinical review2008/02/01English42
Indium-111 capromab pendetide in the management of recurrent prostate cancer2008/02/01English42
Bevacizumab in the management of solid tumors2007/04/01English42
Gefitinib (Iressa®): a novel treatment for non-small cell lung cancer2004/02/01English42
Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma2012/09/01English42
Thrombosis in multiple myeloma2007/03/01English42
Medication adherence to oral anticancer drugs: systematic review2016/03/16English41
Clinical use of PI3K inhibitors in B-cell lymphoid malignancies: today and tomorrow2017/02/06English41
Could valproic acid be an effective anticancer agent? The evidence so far2014/07/14English41
Melphalan and its role in the management of patients with multiple myeloma2007/07/01English41
New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response2005/04/01English41
Lenalidomide in multiple myeloma2006/08/01English41